N-(3-Methoxybenzyl)ethanamine is primarily used in the synthesis of various pharmaceutical compounds, particularly those targeting neurological and psychiatric disorders. It serves as an intermediate in the production of drugs that act on the central nervous system, such as antidepressants and anxiolytics. Additionally, it is utilized in research settings to develop novel therapeutic agents due to its structural properties, which allow for modifications to enhance drug efficacy and selectivity. Its role in organic synthesis also extends to the creation of compounds with potential anti-inflammatory and analgesic properties.